Knight Capital Group’s AbbVie ABBV Stock Holding History

Knight Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$1.86M	Buy	+45,116	New	+$1.97M	0.03%	577

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Knight Capital Group's ABBV Position: Q2 2013 in Review

Knight Capital Group opened a new position in AbbVie (ABBV) in Q2 2013: 45,116 shares worth $1.86M. The stake represents 0.03% of the portfolio and ranks #577 among its holdings.

1,286 funds tracked by Wall St. Rank hold ABBV as of Q2 2013.

Knight Capital Group held 45,116 shares of AbbVie worth $1.86M as of Q2 2013.
AbbVie was a new Knight Capital Group position in Q2 2013.
AbbVie made up 0.03% of Knight Capital Group's portfolio in Q2 2013, its #577 holding.
1,286 funds tracked by Wall St. Rank held AbbVie as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.